Nir Sassi

Insider Reports History

Identity 1 fact
Location
ModIIn, Israel
SEC filing record 1 fact
SEC signature
/s/ Nir Sassi
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Nir Sassi:

Form 4 holding Chief Financial Officer

Indaptus Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
$0
Report date
10 Apr 2025
Price
$0.0710
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Nir Sassi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .